Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
New Jersey bill mandates Medicaid cover fertility drugs and administration services without restrictions for infertile beneficiaries, removing cost barriers to treatment.